- Denosumab - a new potential effect of RANKL inhibitor2014 | Second Faculty of Medicine
- Denosumab in a rheumatologist's clinic2023 | First Faculty of Medicine
- Denosumab in treatment of postmenopausal osteoporosis2013 | First Faculty of Medicine
- Denosumab in patients with skeletal metastases2021 | Faculty of Medicine in Pilsen
- Denosumab - a new agent in the treatment of osteoporosis2011 | Faculty of Medicine in Hradec Králové
- Denosumab - an important part of the treatment of patients with skeletal metastatic disease2020 | Faculty of Medicine in Pilsen
- Denosumab in postmenopausal osteoporosis2011 | First Faculty of Medicine
- Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis +12009 | Faculty of Medicine in Hradec Králové
- Osteoprotegerin and denosumab in pathophysiology and pharmacotherapy of postmenopausal osteoporosis2010 | First Faculty of Medicine
- Denosumab in the treatment ofpostmenopausal osteoporosis and prevention of fractures2010 | First Faculty of Medicine
- Denosumab in the first line treatment of osteoporosis2020 | Third Faculty of Medicine
- Successful treatment of SAPHO syndrome (chronic nonbacterial osteomyelitis and acne) with anakinra and denosumab. Case report and review of therapy2023 | Second Faculty of Medicine
- Denosumab: fast inhibition and fast reversibility of osteoclast function and safety and efficacy in the elderly2011 | First Faculty of Medicine
- Osteoprotective therapy with bisphosphonates or denosumab in patients with multiple myeloma: benefit and risks2017 | First Faculty of Medicine
- Guidelines for diagnosing and therapy of postmenopausal osteoporosis II. Addendum.2010 | Faculty of Medicine in Hradec Králové
- Denosumab v léčbě karcinomu prostaty2016 | First Faculty of Medicine
- Biological therapy of osteoporosis2017 | First Faculty of Medicine
- Supportive care for patients with bone metastases - recommendations for clinical2013 | First Faculty of Medicine
- Adherence to denosumab in the treatment of osteoporosis and its utilization in the Czech Republic2015 | Faculty of Pharmacy in Hradec Králové
- Postavení denosumabu v léčbě nemocných s bronchogenním karcinomem a generalizací do kostí2020 | Third Faculty of Medicine
- Progress in search for new osteoporosis therapies2014 | First Faculty of Medicine
- Denosumab associated with bone density increase and clinical improvement in a long-term hemodialysis patient. Case report and review of the literature2014 | Faculty of Medicine in Hradec Králové
- Real-world Management of Women with Postmenopausal Osteoporosis Treated with Denosumab: A Prospective Observational Study in the Czech Republic and Slovakia2018 | First Faculty of Medicine
- Impact of clinical fractures on health-related quality of life is dependent on time of assessment since fracture: results from the FREEDOM trial2012 | First Faculty of Medicine
- Multidisciplinary approach in the treatment of a comorbid patient with secondary osteoporosis - a clinical case report2016 | Faculty of Medicine in Pilsen
- Atypical femoral fractures - what's new?2021 | First Faculty of Medicine
- Osteonecrosis of the jaw in patients receiving antiresorptive therapy for osteoporosis2013 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine
- Ineffective and failed treatment of osteoporosis2017 | Central Library of Charles University
- New possibility of treatment of glucocorticoid induced osteoporosis2019 | First Faculty of Medicine